Loading...

VRTX VERTEX PHARMACEUTICALS INC Management Changes 8-K Filing

VRTX

VRTX

VERTEX PHARMACEUTICALS INC

(VRTX)

2025 8-K

FDA Application Submitted

Financial Results Report

Financial Results Report

Financial Statements

Impairment Charge

Management Changes

Financial Results

Lease Extension

Financial Results Announcement

Annual Meeting Voting Results

Financial Results

Merger Agreement

Financial Results Announcement

FDA Approval and Pricing An...

Appointment of Nancy Thornb...

Financial Results

Appointment of Director

Financial Results

Annual Meeting Voting Results

Financial Results Announcement

External Links:

On August 4, 2025, Vertex Pharmaceuticals reported its financial results for the second quarter of 2025 and announced the retirement of Chief Scientific Officer David Altshuler, effective August 1, 2026.

AI Assistant

VERTEX PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.